Investigating the roles of regulatory T cells, mast cells and interleukin-9 in the control of skin inflammation by vitamin D

被引:0
|
作者
Shelley Gorman
Sian Geldenhuys
Clare E. Weeden
Michele A. Grimbaldeston
Prue H. Hart
机构
[1] University of Western Australia,Telethon Kids Institute
[2] Genentech Inc,OMNI
[3] University of South Australia and SA Pathology,Biomarker Development
来源
关键词
Vitamin D; Contact dermatitis; Mast cells; Regulatory T cells; Interleukin-9;
D O I
暂无
中图分类号
学科分类号
摘要
Topical application of biologically active vitamin D [1,25-dihydroxyvitamin D (1,25(OH)2D)], or low-calcemic analogues, curb skin inflammation through mechanisms that involve migratory dendritic cells (DCs) and regulatory T (TReg) cells. 1,25(OH)2D also promotes immunoregulation by mast cells, and inhibits the development of T helper type-9 (Th9) cells that secrete interleukin-9 (IL-9). Here, we investigated the ability of topical 1,25(OH)2D to suppress contact dermatitis through an IL-9-dependent process, examining mast cells and IL-9-secreting T cells. Contact dermatitis was modelled in adult BALB/c female mice by initiating a “biphasic ear swelling response” following a single application of 2,4-dinitrofluorobenzene (DNFB). Topical 1,25(OH)2D (125 ng) applied to ear pinnae prior to (but not after) DNFB sensitisation suppressed the efferent phase of the ear swelling response. This dose of 1,25(OH)2D did not cause hypercalcemia. At the peak of the efferent ear swelling response, proportions of TReg (CD3 + Foxp3+) cells and numbers of mast cells were increased in ear skin of 1,25(OH)2D-treated mice. Topical 1,25(OH)2D increased the proportion of Foxp3 + IL-9 + TReg cells and the capacity of TReg cells to secrete IL-9 ex vivo. However, the proportion of the IL-9 + cells of the total TReg cell population was small (< 1%), and the amount of IL-9 secreted by TReg cells from mice treated with IL-9 was low (< 50 pg/ml). Furthermore, injection of anti-IL-9 neutralising antibody (100 µg, intraperitoneally) prior to sensitisation did not significantly reverse the suppressive effects of 1,25(OH)2D. In conclusion, topically applied 1,25(OH)2D suppressed the efferent phase of a biphasic cutaneous ear swelling response through mechanism(s) that may be dependent on mast cells and TReg cells; however, the role of IL-9 in mediating these responses is uncertain. More studies are needed to further characterise the mechanisms by which topical 1,25(OH)2D modulates cell-mediated immune responses central to its suppressive effects upon contact dermatitis.
引用
收藏
页码:221 / 230
页数:9
相关论文
共 50 条
  • [1] Investigating the roles of regulatory T cells, mast cells and interleukin-9 in the control of skin inflammation by vitamin D
    Gorman, Shelley
    Geldenhuys, Sian
    Weeden, Clare E.
    Grimbaldeston, Michele A.
    Hart, Prue H.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2018, 310 (03) : 221 - 230
  • [2] INTERLEUKIN-9 AND MAST CELLS
    Tete, S.
    Nicoletti, M.
    Saggini, A.
    Maccauro, G.
    Rosati, M.
    Conti, F.
    Cianchetti, E.
    Tripodi, D.
    Toniato, E.
    Fulcheri, M.
    Salini, V.
    Caraffa, A.
    Antinolfi, P.
    Frydas, S.
    Pandolfi, F.
    Conti, P.
    Potalivo, G.
    Theoharides, T. C.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2012, 26 (03): : 319 - 326
  • [3] From interleukin-9 to T helper 9 cells
    Stassen, Michael
    Schmitt, Edgar
    Bopp, Tobias
    YEAR IN IMMUNOLOGY, 2012, 1247 : 56 - 68
  • [4] Negative impact of Interleukin-9 on synovial regulatory T cells in rheumatoid arthritis
    Chakraborty, Sushmita
    Gupta, Ranjan
    Kubatzky, Katharina F.
    Kar, Santanu
    Kraus, Franziska, V
    Souto-Carneiro, M. Margarida
    Lorenz, Hanns-Martin
    Kumar, Pankaj
    Kumar, Vijay
    Mitra, Dipendra Kumar
    CLINICAL IMMUNOLOGY, 2023, 257
  • [5] Impact of Interleukin-9 on the Immune Suppressive Functions of Regulatory T Cells in Rheumatoid Arthritis
    Chakraborty, Sushmita
    Gupta, Ranjan
    Kumari, Rinkee
    Mitra, Dipendra Kumar
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] Interleukin-9 and T helper type 9 cells in rheumatic diseases
    Ciccia, F.
    Guggino, G.
    Ferrante, A.
    Cipriani, P.
    Giacomelli, R.
    Triolo, G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 185 (02): : 125 - 132
  • [7] Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis
    Yin Jun-Jie
    Hu Xue-Qiang
    Mao Zhi-Feng
    Bao Jian
    Qiu Wei
    Lu Zheng-Qi
    Wu Hao-Tian
    Zhong Xiao-Nan
    中华医学杂志英文版, 2017, 130 (08) : 964 - 971
  • [8] Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis
    Yin, Jun-Jie
    Hu, Xue-Qiang
    Mao, Zhi-Feng
    Bao, Jian
    Qiu, Wei
    Lu, Zheng-Qi
    Wu, Hao-Tian
    Zhong, Xiao-Nan
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 964 - 971
  • [9] Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases
    Pan, Hai-Feng
    Leng, Rui-Xue
    Li, Xiang-Pei
    Zheng, Song Guo
    Ye, Dong-Qing
    CYTOKINE & GROWTH FACTOR REVIEWS, 2013, 24 (06) : 515 - 522
  • [10] T helper-9 cells and Interleukin-9 in transplantation: The open question
    Assadiasl, Sara
    Fatahi, Yousef
    Nicknam, Mohammad Hossein
    HUMAN IMMUNOLOGY, 2022, 83 (06) : 499 - 508